Cytonics Corporation Email Format

Biotechnology ResearchFlorida, United States11-50 Employees

Cytonics Corporation is a small biotechnology research and development company based in Jupiter, Florida, focused on therapeutics derived from Alpha2 Macroglobulin (A2M), a protease inhibitor. It seeks to out-license A2M-based drugs to strategic partners with late-stage development, commercialization, and marketing capabilities, enabling external expertise while keeping the organization focused. The company has developed a diagnostic biomarker intended to help physicians identify the source of orthopedic pain and is pursuing products for osteoarthritis, back, and joint pain.

Cytonics operates a research laboratory in Jupiter employing scientists and PhD-level researchers focused on musculoskeletal disease therapies. In July 2024, Cytonics announced the launch of the Autologous Platelet-Integrated Concentrate system, which concentrates A2M from a patient’s own blood for injection into damaged joints.

Get verified Cytonics Corporation emails free

Company overview Employee directory